http://www.tinaswish.orgna's Wish will fund $1.6M in grants for eight early detection ovarian cancer research projects in 2017/18.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
NEW YORK, Dec. 5, 2016
/PRNewswire/ -- Tina's Wish, the only nonprofit organization dedicated
exclusively to funding scientific research for the early detection of
ovarian cancer has announced its eight 2017/18 individual grant
recipients after soliciting proposals nationally for the first time.
Researchers from Dana-Farber Cancer Institute, Johns Hopkins Medicine,
Memorial Sloan Kettering Cancer Center, NYU School of Medicine, Penn
Medicine, University of Michigan, University of Virginia and Yale Cancer Center will receive funding.
The Foundation utilized a
team of expert external reviewers in addition to the Tina's Wish
Scientific Advisory Board for the nine-month selection process. Only 13
percent of applicants received funding.
Douglas Levine,
M.D., Director of Gynecologic Oncology at NYU Langone's Perlmutter
Cancer Center and Tina's Wish Scientific Advisory Board Chair, was
overwhelmed by the high quality and quantity of projects received.
"The dedication and drive
of Tina's Wish is being noticed across the country and the foundation is
now in a position to make critical contributions to the mission," said
Dr. Levine. "I truly believe that the work of the foundation will drive
meaningful discovery and interventions in this area that would not
otherwise be possible."
The majority of ovarian
cancer patients are identified in advanced stages due to subtle symptoms
and the lack of an effective early detection screening. Statistically,
only 27 percent of patients diagnosed during Stage III/IV survive for
five years, compared to 92 percent of women diagnosed during Stage I,
demonstrating that tools for early detection are critical to changing
the global impact of the disease.
Since its inception nine years ago, Tina's Wish has raised more than $8.5 million
for ovarian cancer research grants and has become the third largest
private funding source dedicated to early detection ovarian cancer
research. The Foundation created a collaborative research consortium in
2015, bringing together scientists from five world-class institutions
who are sharing uniform cancer specimens and developing innovative
prevention and diagnostic strategies.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.